-
321
Bio-primed machine learning to enhance discovery of relevant biomarkers
Published 2025-02-01“…Abstract Precision medicine relies on identifying reliable biomarkers for gene dependencies to tailor individualized therapeutic strategies. …”
Get full text
Article -
322
Enhancing precision in cancer treatment: the role of gene therapy and immune modulation in oncology
Published 2025-01-01“…CRISPR-Cas9, a revolutionary tool in precision medicine, enables precise editing of cancer-driving mutations, enhancing immune responses and disrupting tumor growth mechanisms. …”
Get full text
Article -
323
Bioactive compounds of Calotropis gigantea for cancer treatment
Published 2024-06-01“…C. gigantea represents a promising source of bioactive compounds for cancer treatment, with potential applications in precision medicine and combination therapy strategies. Continued research efforts, interdisciplinary collaborations, and investment in innovation are essential to realize the full therapeutic potential of C. gigantea-derived compounds and improve patient outcomes in the fight against cancer.…”
Get full text
Article -
324
Navigating a challenging path: precision disease treatment with tailored oral nano-armor-probiotics
Published 2025-02-01“…Ultimately, this review aspires to guide the advancement of nano-armored probiotic therapies, driving progress in precision medicine and paving the way for groundbreaking treatment modalities. …”
Get full text
Article -
325
Effect of Bacille Calmette–Guérin vaccination on immune responses to SARS‐CoV‐2 and COVID‐19 vaccination
Published 2025-01-01Get full text
Article -
326
Targeting ferroptosis in prostate cancer management: molecular mechanisms, multidisciplinary strategies and translational perspectives
Published 2025-02-01“…Hence deciphering the role of ferroptosis in carcinogenesis would provide novel insights and strategies for precision medicine and personalized healthcare against PCa. …”
Get full text
Article -
327
Characterization of Somatic Mutations in Malaysian Luminal Breast Cancer
Published 2018-12-01“…Therefore, it is clinically important to identify actionable mutated genes or pathways implicated in our local breast cancer patients to establish a more defined framework for precision medicine and clinical trials. In this discovery study, a total of nine pairs of newly diagnosed luminal breast cancer cases (>80% tumour content) and their matched normal samples were subjected to exome sequencing. …”
Get full text
Article -
328
Chromatin remodeling (SWI/SNF) complexes, cancer, and response to immunotherapy
Published 2022-09-01Get full text
Article -
329
Immunoinfiltration Analysis of Mitochondrial Damage‐Related Genes in Lung Adenocarcinoma and Construction of a Classification and Prognostic Model Integrated With WGCNA and Machine...
Published 2025-01-01“…The gene module and models identified have potential applications in LUAD classification and prognosis, offering novel markers for precision medicine. Conclusion This study uncovers the relationship between mitochondrial damage and immune infiltration in LUAD, paving the way for molecular classification, prognosis prediction, and personalized treatment strategies.…”
Get full text
Article -
330
Chimerism in Myeloid Malignancies following Stem Cell Transplantation Using FluBu4 with and without Busulfan Pharmacokinetics versus BuCy
Published 2017-01-01“…In the era of precision medicine, the impact of personalized dosing of busulfan is not clear. …”
Get full text
Article -
331
The interplay of sex and genotype in disease associations: a comprehensive network analysis in the UK Biobank
Published 2025-01-01“…Conclusions Our analysis affirms the presence of GxS interactions in cross-phenotype associations, emphasizing the need to investigate the role of sex in disease onset and its importance in biomedical discovery and precision medicine research.…”
Get full text
Article -
332
Fetal-Perinatal Exposure to Bisphenol-A Affects Quality of Spermatozoa in Adulthood Mouse
Published 2020-01-01Get full text
Article -
333
Evaluation of Overall Survival Predictions In Inoperable Pancreas Ductal Adenocarcinoma
Published 2022-02-01“…Objective: In this study, we aimed to determine the independent predictive parameters of overall survival (OS) ofpatients with inoperable pancreatic ductal adenocarcinoma (PDAC) and to investigate whether these parameterscan be used as potential biomarkers to shape precision medicine practices for PDAC patients.Material and Methods: The clinical and pathological data of patients who were diagnosed with inoperablepancreatic ductal adenocarcinoma between January 2016 and December 2019 and who underwent18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) in our departmentwere retrospectively analyzed. …”
Get full text
Article -
334
Case report: A case of type 1 diabetes with diabetic ketoacidosis induced by envafolimab treatment in hepatocellular carcinoma
Published 2025-01-01“…Recognizing the limitations of current understanding, there is a clear call for further research, particularly on identifying biomarkers that may predict adverse reactions to immunotherapy, to guide precision medicine and improve patient safety.…”
Get full text
Article -
335
Predicting Alzheimer Disease From Mild Cognitive Impairment With a Deep Belief Network Based on 18F-FDG-PET Images
Published 2019-09-01“…This method may be a powerful tool for personalized precision medicine in the population with prediction of early AD progression.…”
Get full text
Article -
336
IMMUNE THROMBOTIC THROMBOCYTOPENIC PURPURA: PATHOPHYSIOLOGY, DIAGNOSIS AND OPEN ISSUES.
Published 2024-06-01Get full text
Article -
337
Progress in the role of nanoparticles in the diagnosis and treatment of bone and joint tuberculosis
Published 2025-01-01“…This review summarizes recent advancements in nanomaterials for diagnosing and treating BJTB and identifies key areas for future research, laying the groundwork for advancing precision medicine and personalized treatments.…”
Get full text
Article -
338
Real-world clinical multi-omics analyses reveal bifurcation of ER-independent and ER-dependent drug resistance to CDK4/6 inhibitors
Published 2025-01-01“…Abstract To better understand drug resistance mechanisms to CDK4/6 inhibitors and inform precision medicine, we analyze real-world multi-omics data from 400 HR+/HER2- metastatic breast cancer patients treated with CDK4/6 inhibitors plus endocrine therapies, including 200 pre-treatment and 227 post-progression samples. …”
Get full text
Article -
339
-
340